Global Bacteriophage Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Bacteriophage Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 124

Published Date: 02 Feb 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Bacteriophage Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Bacteriophage Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Bacteriophage Therapy market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Bacteriophage Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oral
Topical
Parenteral

Market segment by Application, can be divided into
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other

Market segment by players, this report covers
Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Bacteriophage Therapy
1.2 Classification of Bacteriophage Therapy by Type
1.2.1 Overview: Global Bacteriophage Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Bacteriophage Therapy Revenue Market Share by Type in 2020
1.2.3 Oral
1.2.4 Topical
1.2.5 Parenteral
1.3 Global Bacteriophage Therapy Market by Application
1.3.1 Overview: Global Bacteriophage Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Organ Transplantation
1.3.3 Bacterial Infections
1.3.4 Alcoholic Hepatitis
1.3.5 Other
1.4 Global Bacteriophage Therapy Market Size & Forecast
1.5 Global Bacteriophage Therapy Market Size and Forecast by Region
1.5.1 Global Bacteriophage Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Bacteriophage Therapy Market Size by Region, (2016-2021)
1.5.3 North America Bacteriophage Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Bacteriophage Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Bacteriophage Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Bacteriophage Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Bacteriophage Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Bacteriophage Therapy Market Drivers
1.6.2 Bacteriophage Therapy Market Restraints
1.6.3 Bacteriophage Therapy Trends Analysis

2 Company Profiles
2.1 Armata Pharmaceuticals, Inc.
2.1.1 Armata Pharmaceuticals, Inc. Details
2.1.2 Armata Pharmaceuticals, Inc. Major Business
2.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product and Solutions
2.1.4 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Armata Pharmaceuticals, Inc. Recent Developments and Future Plans
2.2 Eliava Biopreparations Ltd.
2.2.1 Eliava Biopreparations Ltd. Details
2.2.2 Eliava Biopreparations Ltd. Major Business
2.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Product and Solutions
2.2.4 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Eliava Biopreparations Ltd. Recent Developments and Future Plans
2.3 Pherecydes Pharma
2.3.1 Pherecydes Pharma Details
2.3.2 Pherecydes Pharma Major Business
2.3.3 Pherecydes Pharma Bacteriophage Therapy Product and Solutions
2.3.4 Pherecydes Pharma Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pherecydes Pharma Recent Developments and Future Plans
2.4 Intralytix, Inc.
2.4.1 Intralytix, Inc. Details
2.4.2 Intralytix, Inc. Major Business
2.4.3 Intralytix, Inc. Bacteriophage Therapy Product and Solutions
2.4.4 Intralytix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Intralytix, Inc. Recent Developments and Future Plans
2.5 Phagelux Inc.
2.5.1 Phagelux Inc. Details
2.5.2 Phagelux Inc. Major Business
2.5.3 Phagelux Inc. Bacteriophage Therapy Product and Solutions
2.5.4 Phagelux Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Phagelux Inc. Recent Developments and Future Plans
2.6 Nextbiotics
2.6.1 Nextbiotics Details
2.6.2 Nextbiotics Major Business
2.6.3 Nextbiotics Bacteriophage Therapy Product and Solutions
2.6.4 Nextbiotics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Nextbiotics Recent Developments and Future Plans
2.7 InnoPhage, Ltd
2.7.1 InnoPhage, Ltd Details
2.7.2 InnoPhage, Ltd Major Business
2.7.3 InnoPhage, Ltd Bacteriophage Therapy Product and Solutions
2.7.4 InnoPhage, Ltd Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 InnoPhage, Ltd Recent Developments and Future Plans
2.8 Locus Biosciences, Inc.
2.8.1 Locus Biosciences, Inc. Details
2.8.2 Locus Biosciences, Inc. Major Business
2.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Product and Solutions
2.8.4 Locus Biosciences, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Locus Biosciences, Inc. Recent Developments and Future Plans
2.9 TechnoPhage
2.9.1 TechnoPhage Details
2.9.2 TechnoPhage Major Business
2.9.3 TechnoPhage Bacteriophage Therapy Product and Solutions
2.9.4 TechnoPhage Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 TechnoPhage Recent Developments and Future Plans
2.10 Eligo Bioscience SA
2.10.1 Eligo Bioscience SA Details
2.10.2 Eligo Bioscience SA Major Business
2.10.3 Eligo Bioscience SA Bacteriophage Therapy Product and Solutions
2.10.4 Eligo Bioscience SA Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Eligo Bioscience SA Recent Developments and Future Plans
2.11 Phagomed Biopharma GmbH.
2.11.1 Phagomed Biopharma GmbH. Details
2.11.2 Phagomed Biopharma GmbH. Major Business
2.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Product and Solutions
2.11.4 Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Phagomed Biopharma GmbH. Recent Developments and Future Plans
2.12 PhagePro, Inc.
2.12.1 PhagePro, Inc. Details
2.12.2 PhagePro, Inc. Major Business
2.12.3 PhagePro, Inc. Bacteriophage Therapy Product and Solutions
2.12.4 PhagePro, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 PhagePro, Inc. Recent Developments and Future Plans
2.13 Adaptive Phage Therapeutics, Inc.
2.13.1 Adaptive Phage Therapeutics, Inc. Details
2.13.2 Adaptive Phage Therapeutics, Inc. Major Business
2.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product and Solutions
2.13.4 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Adaptive Phage Therapeutics, Inc. Recent Developments and Future Plans
2.14 EnBiotix, Inc.
2.14.1 EnBiotix, Inc. Details
2.14.2 EnBiotix, Inc. Major Business
2.14.3 EnBiotix, Inc. Bacteriophage Therapy Product and Solutions
2.14.4 EnBiotix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 EnBiotix, Inc. Recent Developments and Future Plans
2.15 Intodeworld, Inc.
2.15.1 Intodeworld, Inc. Details
2.15.2 Intodeworld, Inc. Major Business
2.15.3 Intodeworld, Inc. Bacteriophage Therapy Product and Solutions
2.15.4 Intodeworld, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Intodeworld, Inc. Recent Developments and Future Plans
2.16 BiomX Ltd.
2.16.1 BiomX Ltd. Details
2.16.2 BiomX Ltd. Major Business
2.16.3 BiomX Ltd. Bacteriophage Therapy Product and Solutions
2.16.4 BiomX Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 BiomX Ltd. Recent Developments and Future Plans
2.17 Phi Therapeutics
2.17.1 Phi Therapeutics Details
2.17.2 Phi Therapeutics Major Business
2.17.3 Phi Therapeutics Bacteriophage Therapy Product and Solutions
2.17.4 Phi Therapeutics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Phi Therapeutics Recent Developments and Future Plans
2.18 Fixed-phage Ltd.
2.18.1 Fixed-phage Ltd. Details
2.18.2 Fixed-phage Ltd. Major Business
2.18.3 Fixed-phage Ltd. Bacteriophage Therapy Product and Solutions
2.18.4 Fixed-phage Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Fixed-phage Ltd. Recent Developments and Future Plans
2.19 Micreos BV
2.19.1 Micreos BV Details
2.19.2 Micreos BV Major Business
2.19.3 Micreos BV Bacteriophage Therapy Product and Solutions
2.19.4 Micreos BV Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Micreos BV Recent Developments and Future Plans
2.20 ContraFect Corporation
2.20.1 ContraFect Corporation Details
2.20.2 ContraFect Corporation Major Business
2.20.3 ContraFect Corporation Bacteriophage Therapy Product and Solutions
2.20.4 ContraFect Corporation Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 ContraFect Corporation Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Bacteriophage Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Bacteriophage Therapy Players Market Share
3.2.2 Top 10 Bacteriophage Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Bacteriophage Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Bacteriophage Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Bacteriophage Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global Bacteriophage Therapy Revenue Market Share by Application (2016-2021)
5.2 Bacteriophage Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America Bacteriophage Therapy Revenue by Type (2016-2026)
6.2 North America Bacteriophage Therapy Revenue by Application (2016-2026)
6.3 North America Bacteriophage Therapy Market Size by Country
6.3.1 North America Bacteriophage Therapy Revenue by Country (2016-2026)
6.3.2 United States Bacteriophage Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Bacteriophage Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Bacteriophage Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe Bacteriophage Therapy Revenue by Type (2016-2026)
7.2 Europe Bacteriophage Therapy Revenue by Application (2016-2026)
7.3 Europe Bacteriophage Therapy Market Size by Country
7.3.1 Europe Bacteriophage Therapy Revenue by Country (2016-2026)
7.3.2 Germany Bacteriophage Therapy Market Size and Forecast (2016-2026)
7.3.3 France Bacteriophage Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Bacteriophage Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Bacteriophage Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Bacteriophage Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Bacteriophage Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Bacteriophage Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Bacteriophage Therapy Market Size by Region
8.3.1 Asia-Pacific Bacteriophage Therapy Revenue by Region (2016-2026)
8.3.2 China Bacteriophage Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Bacteriophage Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Bacteriophage Therapy Market Size and Forecast (2016-2026)
8.3.5 India Bacteriophage Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Bacteriophage Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Bacteriophage Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America Bacteriophage Therapy Revenue by Type (2016-2026)
9.2 South America Bacteriophage Therapy Revenue by Application (2016-2026)
9.3 South America Bacteriophage Therapy Market Size by Country
9.3.1 South America Bacteriophage Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Bacteriophage Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Bacteriophage Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Bacteriophage Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Bacteriophage Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Bacteriophage Therapy Market Size by Country
10.3.1 Middle East & Africa Bacteriophage Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Bacteriophage Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Bacteriophage Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Bacteriophage Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Bacteriophage Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Bacteriophage Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Bacteriophage Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Bacteriophage Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Bacteriophage Therapy Revenue Market Share by Region (2021-2026)
Table 6. Armata Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Armata Pharmaceuticals, Inc. Major Business
Table 8. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product and Solutions
Table 9. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Eliava Biopreparations Ltd. Corporate Information, Head Office, and Major Competitors
Table 11. Eliava Biopreparations Ltd. Major Business
Table 12. Eliava Biopreparations Ltd. Bacteriophage Therapy Product and Solutions
Table 13. Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pherecydes Pharma Corporate Information, Head Office, and Major Competitors
Table 15. Pherecydes Pharma Major Business
Table 16. Pherecydes Pharma Bacteriophage Therapy Product and Solutions
Table 17. Pherecydes Pharma Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Intralytix, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Intralytix, Inc. Major Business
Table 20. Intralytix, Inc. Bacteriophage Therapy Product and Solutions
Table 21. Intralytix, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Phagelux Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Phagelux Inc. Major Business
Table 24. Phagelux Inc. Bacteriophage Therapy Product and Solutions
Table 25. Phagelux Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Nextbiotics Corporate Information, Head Office, and Major Competitors
Table 27. Nextbiotics Major Business
Table 28. Nextbiotics Bacteriophage Therapy Product and Solutions
Table 29. Nextbiotics Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. InnoPhage, Ltd Corporate Information, Head Office, and Major Competitors
Table 31. InnoPhage, Ltd Major Business
Table 32. InnoPhage, Ltd Bacteriophage Therapy Product and Solutions
Table 33. InnoPhage, Ltd Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Locus Biosciences, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Locus Biosciences, Inc. Major Business
Table 36. Locus Biosciences, Inc. Bacteriophage Therapy Product and Solutions
Table 37. Locus Biosciences, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. TechnoPhage Corporate Information, Head Office, and Major Competitors
Table 39. TechnoPhage Major Business
Table 40. TechnoPhage Bacteriophage Therapy Product and Solutions
Table 41. TechnoPhage Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Eligo Bioscience SA Corporate Information, Head Office, and Major Competitors
Table 43. Eligo Bioscience SA Major Business
Table 44. Eligo Bioscience SA Bacteriophage Therapy Product and Solutions
Table 45. Eligo Bioscience SA Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Phagomed Biopharma GmbH. Corporate Information, Head Office, and Major Competitors
Table 47. Phagomed Biopharma GmbH. Major Business
Table 48. Phagomed Biopharma GmbH. Bacteriophage Therapy Product and Solutions
Table 49. Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. PhagePro, Inc. Corporate Information, Head Office, and Major Competitors
Table 51. PhagePro, Inc. Major Business
Table 52. PhagePro, Inc. Bacteriophage Therapy Product and Solutions
Table 53. PhagePro, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Adaptive Phage Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Adaptive Phage Therapeutics, Inc. Major Business
Table 56. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product and Solutions
Table 57. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. EnBiotix, Inc. Corporate Information, Head Office, and Major Competitors
Table 59. EnBiotix, Inc. Major Business
Table 60. EnBiotix, Inc. Bacteriophage Therapy Product and Solutions
Table 61. EnBiotix, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Intodeworld, Inc. Corporate Information, Head Office, and Major Competitors
Table 63. Intodeworld, Inc. Major Business
Table 64. Intodeworld, Inc. Bacteriophage Therapy Product and Solutions
Table 65. Intodeworld, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. BiomX Ltd. Corporate Information, Head Office, and Major Competitors
Table 67. BiomX Ltd. Major Business
Table 68. BiomX Ltd. Bacteriophage Therapy Product and Solutions
Table 69. BiomX Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Phi Therapeutics Corporate Information, Head Office, and Major Competitors
Table 71. Phi Therapeutics Major Business
Table 72. Phi Therapeutics Bacteriophage Therapy Product and Solutions
Table 73. Phi Therapeutics Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Fixed-phage Ltd. Corporate Information, Head Office, and Major Competitors
Table 75. Fixed-phage Ltd. Major Business
Table 76. Fixed-phage Ltd. Bacteriophage Therapy Product and Solutions
Table 77. Fixed-phage Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Micreos BV Corporate Information, Head Office, and Major Competitors
Table 79. Micreos BV Major Business
Table 80. Micreos BV Bacteriophage Therapy Product and Solutions
Table 81. Micreos BV Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. ContraFect Corporation Corporate Information, Head Office, and Major Competitors
Table 83. ContraFect Corporation Major Business
Table 84. ContraFect Corporation Bacteriophage Therapy Product and Solutions
Table 85. ContraFect Corporation Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Global Bacteriophage Therapy Revenue (USD Million) by Players (2019-2021)
Table 87. Global Bacteriophage Therapy Revenue Share by Players (2019-2021)
Table 88. Breakdown of Bacteriophage Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Bacteriophage Therapy Players Head Office, Products and Services Provided
Table 90. Bacteriophage Therapy Mergers & Acquisitions in the Past Five Years
Table 91. Bacteriophage Therapy New Entrants and Expansion Plans
Table 92. Global Bacteriophage Therapy Revenue (USD Million) by Type (2016-2021)
Table 93. Global Bacteriophage Therapy Revenue Share by Type (2016-2021)
Table 94. Global Bacteriophage Therapy Revenue Forecast by Type (2021-2026)
Table 95. Global Bacteriophage Therapy Revenue by Application (2016-2021)
Table 96. Global Bacteriophage Therapy Revenue Forecast by Application (2021-2026)
Table 97. North America Bacteriophage Therapy Revenue by Type (2016-2021) & (USD Million)
Table 98. North America Bacteriophage Therapy Revenue by Type (2021-2026) & (USD Million)
Table 99. North America Bacteriophage Therapy Revenue by Application (2016-2021) & (USD Million)
Table 100. North America Bacteriophage Therapy Revenue by Application (2021-2026) & (USD Million)
Table 101. North America Bacteriophage Therapy Revenue by Country (2016-2021) & (USD Million)
Table 102. North America Bacteriophage Therapy Revenue by Country (2021-2026) & (USD Million)
Table 103. Europe Bacteriophage Therapy Revenue by Type (2016-2021) & (USD Million)
Table 104. Europe Bacteriophage Therapy Revenue by Type (2021-2026) & (USD Million)
Table 105. Europe Bacteriophage Therapy Revenue by Application (2016-2021) & (USD Million)
Table 106. Europe Bacteriophage Therapy Revenue by Application (2021-2026) & (USD Million)
Table 107. Europe Bacteriophage Therapy Revenue by Country (2016-2021) & (USD Million)
Table 108. Europe Bacteriophage Therapy Revenue by Country (2021-2026) & (USD Million)
Table 109. Asia-Pacific Bacteriophage Therapy Revenue by Type (2016-2021) & (USD Million)
Table 110. Asia-Pacific Bacteriophage Therapy Revenue by Type (2021-2026) & (USD Million)
Table 111. Asia-Pacific Bacteriophage Therapy Revenue by Application (2016-2021) & (USD Million)
Table 112. Asia-Pacific Bacteriophage Therapy Revenue by Application (2021-2026) & (USD Million)
Table 113. Asia-Pacific Bacteriophage Therapy Revenue by Region (2016-2021) & (USD Million)
Table 114. Asia-Pacific Bacteriophage Therapy Revenue by Region (2021-2026) & (USD Million)
Table 115. South America Bacteriophage Therapy Revenue by Type (2016-2021) & (USD Million)
Table 116. South America Bacteriophage Therapy Revenue by Type (2021-2026) & (USD Million)
Table 117. South America Bacteriophage Therapy Revenue by Application (2016-2021) & (USD Million)
Table 118. South America Bacteriophage Therapy Revenue by Application (2021-2026) & (USD Million)
Table 119. South America Bacteriophage Therapy Revenue by Country (2016-2021) & (USD Million)
Table 120. South America Bacteriophage Therapy Revenue by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Bacteriophage Therapy Revenue by Type (2016-2021) & (USD Million)
Table 122. Middle East & Africa Bacteriophage Therapy Revenue by Type (2021-2026) & (USD Million)
Table 123. Middle East & Africa Bacteriophage Therapy Revenue by Application (2016-2021) & (USD Million)
Table 124. Middle East & Africa Bacteriophage Therapy Revenue by Application (2021-2026) & (USD Million)
Table 125. Middle East & Africa Bacteriophage Therapy Revenue by Country (2016-2021) & (USD Million)
Table 126. Middle East & Africa Bacteriophage Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Bacteriophage Therapy Picture
Figure 2. Global Bacteriophage Therapy Revenue Market Share by Type in 2020
Figure 3. Oral
Figure 4. Topical
Figure 5. Parenteral
Figure 6. Bacteriophage Therapy Revenue Market Share by Application in 2020
Figure 7. Organ Transplantation Picture
Figure 8. Bacterial Infections Picture
Figure 9. Alcoholic Hepatitis Picture
Figure 10. Other Picture
Figure 11. Global Bacteriophage Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Bacteriophage Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Bacteriophage Therapy Revenue Market Share by Region (2016-2026)
Figure 14. Global Bacteriophage Therapy Revenue Market Share by Region in 2020
Figure 15. North America Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Bacteriophage Therapy Market Drivers
Figure 21. Bacteriophage Therapy Market Restraints
Figure 22. Bacteriophage Therapy Market Trends
Figure 23. Armata Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 24. Eliava Biopreparations Ltd. Recent Developments and Future Plans
Figure 25. Pherecydes Pharma Recent Developments and Future Plans
Figure 26. Intralytix, Inc. Recent Developments and Future Plans
Figure 27. Phagelux Inc. Recent Developments and Future Plans
Figure 28. Nextbiotics Recent Developments and Future Plans
Figure 29. InnoPhage, Ltd Recent Developments and Future Plans
Figure 30. Locus Biosciences, Inc. Recent Developments and Future Plans
Figure 31. TechnoPhage Recent Developments and Future Plans
Figure 32. Eligo Bioscience SA Recent Developments and Future Plans
Figure 33. Phagomed Biopharma GmbH. Recent Developments and Future Plans
Figure 34. PhagePro, Inc. Recent Developments and Future Plans
Figure 35. Adaptive Phage Therapeutics, Inc. Recent Developments and Future Plans
Figure 36. EnBiotix, Inc. Recent Developments and Future Plans
Figure 37. Intodeworld, Inc. Recent Developments and Future Plans
Figure 38. BiomX Ltd. Recent Developments and Future Plans
Figure 39. Phi Therapeutics Recent Developments and Future Plans
Figure 40. Fixed-phage Ltd. Recent Developments and Future Plans
Figure 41. Micreos BV Recent Developments and Future Plans
Figure 42. ContraFect Corporation Recent Developments and Future Plans
Figure 43. Global Bacteriophage Therapy Revenue Share by Players in 2020
Figure 44. Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 45. Global Top 3 Players Bacteriophage Therapy Revenue Market Share in 2020
Figure 46. Global Top 10 Players Bacteriophage Therapy Revenue Market Share in 2020
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 48. Global Bacteriophage Therapy Revenue Share by Type in 2020
Figure 49. Global Bacteriophage Therapy Market Share Forecast by Type (2021-2026)
Figure 50. Global Bacteriophage Therapy Revenue Share by Application in 2020
Figure 51. Global Bacteriophage Therapy Market Share Forecast by Application (2021-2026)
Figure 52. North America Bacteriophage Therapy Sales Market Share by Type (2016-2026)
Figure 53. North America Bacteriophage Therapy Sales Market Share by Application (2016-2026)
Figure 54. North America Bacteriophage Therapy Revenue Market Share by Country (2016-2026)
Figure 55. United States Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Canada Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Mexico Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Europe Bacteriophage Therapy Sales Market Share by Type (2016-2026)
Figure 59. Europe Bacteriophage Therapy Sales Market Share by Application (2016-2026)
Figure 60. Europe Bacteriophage Therapy Revenue Market Share by Country (2016-2026)
Figure 61. Germany Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. France Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. United Kingdom Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Russia Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Italy Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Asia-Pacific Bacteriophage Therapy Sales Market Share by Type (2016-2026)
Figure 67. Asia-Pacific Bacteriophage Therapy Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Bacteriophage Therapy Revenue Market Share by Region (2016-2026)
Figure 69. China Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Japan Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South Korea Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. India Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Southeast Asia Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Australia Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South America Bacteriophage Therapy Sales Market Share by Type (2016-2026)
Figure 76. South America Bacteriophage Therapy Sales Market Share by Application (2016-2026)
Figure 77. South America Bacteriophage Therapy Revenue Market Share by Country (2016-2026)
Figure 78. Brazil Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Argentina Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Middle East and Africa Bacteriophage Therapy Sales Market Share by Type (2016-2026)
Figure 81. Middle East and Africa Bacteriophage Therapy Sales Market Share by Application (2016-2026)
Figure 82. Middle East and Africa Bacteriophage Therapy Revenue Market Share by Country (2016-2026)
Figure 83. Turkey Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Saudi Arabia Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. UAE Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Bacteriophage Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Bacteriophage Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 124

Published Date: 02 Feb 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Bacteriophage Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Bacteriophage Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Bacteriophage Therapy market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Bacteriophage Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oral
Topical
Parenteral

Market segment by Application, can be divided into
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other

Market segment by players, this report covers
Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Bacteriophage Therapy
1.2 Classification of Bacteriophage Therapy by Type
1.2.1 Overview: Global Bacteriophage Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Bacteriophage Therapy Revenue Market Share by Type in 2020
1.2.3 Oral
1.2.4 Topical
1.2.5 Parenteral
1.3 Global Bacteriophage Therapy Market by Application
1.3.1 Overview: Global Bacteriophage Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Organ Transplantation
1.3.3 Bacterial Infections
1.3.4 Alcoholic Hepatitis
1.3.5 Other
1.4 Global Bacteriophage Therapy Market Size & Forecast
1.5 Global Bacteriophage Therapy Market Size and Forecast by Region
1.5.1 Global Bacteriophage Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Bacteriophage Therapy Market Size by Region, (2016-2021)
1.5.3 North America Bacteriophage Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Bacteriophage Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Bacteriophage Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Bacteriophage Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Bacteriophage Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Bacteriophage Therapy Market Drivers
1.6.2 Bacteriophage Therapy Market Restraints
1.6.3 Bacteriophage Therapy Trends Analysis

2 Company Profiles
2.1 Armata Pharmaceuticals, Inc.
2.1.1 Armata Pharmaceuticals, Inc. Details
2.1.2 Armata Pharmaceuticals, Inc. Major Business
2.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product and Solutions
2.1.4 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Armata Pharmaceuticals, Inc. Recent Developments and Future Plans
2.2 Eliava Biopreparations Ltd.
2.2.1 Eliava Biopreparations Ltd. Details
2.2.2 Eliava Biopreparations Ltd. Major Business
2.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Product and Solutions
2.2.4 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Eliava Biopreparations Ltd. Recent Developments and Future Plans
2.3 Pherecydes Pharma
2.3.1 Pherecydes Pharma Details
2.3.2 Pherecydes Pharma Major Business
2.3.3 Pherecydes Pharma Bacteriophage Therapy Product and Solutions
2.3.4 Pherecydes Pharma Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pherecydes Pharma Recent Developments and Future Plans
2.4 Intralytix, Inc.
2.4.1 Intralytix, Inc. Details
2.4.2 Intralytix, Inc. Major Business
2.4.3 Intralytix, Inc. Bacteriophage Therapy Product and Solutions
2.4.4 Intralytix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Intralytix, Inc. Recent Developments and Future Plans
2.5 Phagelux Inc.
2.5.1 Phagelux Inc. Details
2.5.2 Phagelux Inc. Major Business
2.5.3 Phagelux Inc. Bacteriophage Therapy Product and Solutions
2.5.4 Phagelux Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Phagelux Inc. Recent Developments and Future Plans
2.6 Nextbiotics
2.6.1 Nextbiotics Details
2.6.2 Nextbiotics Major Business
2.6.3 Nextbiotics Bacteriophage Therapy Product and Solutions
2.6.4 Nextbiotics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Nextbiotics Recent Developments and Future Plans
2.7 InnoPhage, Ltd
2.7.1 InnoPhage, Ltd Details
2.7.2 InnoPhage, Ltd Major Business
2.7.3 InnoPhage, Ltd Bacteriophage Therapy Product and Solutions
2.7.4 InnoPhage, Ltd Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 InnoPhage, Ltd Recent Developments and Future Plans
2.8 Locus Biosciences, Inc.
2.8.1 Locus Biosciences, Inc. Details
2.8.2 Locus Biosciences, Inc. Major Business
2.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Product and Solutions
2.8.4 Locus Biosciences, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Locus Biosciences, Inc. Recent Developments and Future Plans
2.9 TechnoPhage
2.9.1 TechnoPhage Details
2.9.2 TechnoPhage Major Business
2.9.3 TechnoPhage Bacteriophage Therapy Product and Solutions
2.9.4 TechnoPhage Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 TechnoPhage Recent Developments and Future Plans
2.10 Eligo Bioscience SA
2.10.1 Eligo Bioscience SA Details
2.10.2 Eligo Bioscience SA Major Business
2.10.3 Eligo Bioscience SA Bacteriophage Therapy Product and Solutions
2.10.4 Eligo Bioscience SA Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Eligo Bioscience SA Recent Developments and Future Plans
2.11 Phagomed Biopharma GmbH.
2.11.1 Phagomed Biopharma GmbH. Details
2.11.2 Phagomed Biopharma GmbH. Major Business
2.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Product and Solutions
2.11.4 Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Phagomed Biopharma GmbH. Recent Developments and Future Plans
2.12 PhagePro, Inc.
2.12.1 PhagePro, Inc. Details
2.12.2 PhagePro, Inc. Major Business
2.12.3 PhagePro, Inc. Bacteriophage Therapy Product and Solutions
2.12.4 PhagePro, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 PhagePro, Inc. Recent Developments and Future Plans
2.13 Adaptive Phage Therapeutics, Inc.
2.13.1 Adaptive Phage Therapeutics, Inc. Details
2.13.2 Adaptive Phage Therapeutics, Inc. Major Business
2.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product and Solutions
2.13.4 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Adaptive Phage Therapeutics, Inc. Recent Developments and Future Plans
2.14 EnBiotix, Inc.
2.14.1 EnBiotix, Inc. Details
2.14.2 EnBiotix, Inc. Major Business
2.14.3 EnBiotix, Inc. Bacteriophage Therapy Product and Solutions
2.14.4 EnBiotix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 EnBiotix, Inc. Recent Developments and Future Plans
2.15 Intodeworld, Inc.
2.15.1 Intodeworld, Inc. Details
2.15.2 Intodeworld, Inc. Major Business
2.15.3 Intodeworld, Inc. Bacteriophage Therapy Product and Solutions
2.15.4 Intodeworld, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Intodeworld, Inc. Recent Developments and Future Plans
2.16 BiomX Ltd.
2.16.1 BiomX Ltd. Details
2.16.2 BiomX Ltd. Major Business
2.16.3 BiomX Ltd. Bacteriophage Therapy Product and Solutions
2.16.4 BiomX Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 BiomX Ltd. Recent Developments and Future Plans
2.17 Phi Therapeutics
2.17.1 Phi Therapeutics Details
2.17.2 Phi Therapeutics Major Business
2.17.3 Phi Therapeutics Bacteriophage Therapy Product and Solutions
2.17.4 Phi Therapeutics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Phi Therapeutics Recent Developments and Future Plans
2.18 Fixed-phage Ltd.
2.18.1 Fixed-phage Ltd. Details
2.18.2 Fixed-phage Ltd. Major Business
2.18.3 Fixed-phage Ltd. Bacteriophage Therapy Product and Solutions
2.18.4 Fixed-phage Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Fixed-phage Ltd. Recent Developments and Future Plans
2.19 Micreos BV
2.19.1 Micreos BV Details
2.19.2 Micreos BV Major Business
2.19.3 Micreos BV Bacteriophage Therapy Product and Solutions
2.19.4 Micreos BV Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Micreos BV Recent Developments and Future Plans
2.20 ContraFect Corporation
2.20.1 ContraFect Corporation Details
2.20.2 ContraFect Corporation Major Business
2.20.3 ContraFect Corporation Bacteriophage Therapy Product and Solutions
2.20.4 ContraFect Corporation Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 ContraFect Corporation Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Bacteriophage Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Bacteriophage Therapy Players Market Share
3.2.2 Top 10 Bacteriophage Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Bacteriophage Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Bacteriophage Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Bacteriophage Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global Bacteriophage Therapy Revenue Market Share by Application (2016-2021)
5.2 Bacteriophage Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America Bacteriophage Therapy Revenue by Type (2016-2026)
6.2 North America Bacteriophage Therapy Revenue by Application (2016-2026)
6.3 North America Bacteriophage Therapy Market Size by Country
6.3.1 North America Bacteriophage Therapy Revenue by Country (2016-2026)
6.3.2 United States Bacteriophage Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Bacteriophage Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Bacteriophage Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe Bacteriophage Therapy Revenue by Type (2016-2026)
7.2 Europe Bacteriophage Therapy Revenue by Application (2016-2026)
7.3 Europe Bacteriophage Therapy Market Size by Country
7.3.1 Europe Bacteriophage Therapy Revenue by Country (2016-2026)
7.3.2 Germany Bacteriophage Therapy Market Size and Forecast (2016-2026)
7.3.3 France Bacteriophage Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Bacteriophage Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Bacteriophage Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Bacteriophage Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Bacteriophage Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Bacteriophage Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Bacteriophage Therapy Market Size by Region
8.3.1 Asia-Pacific Bacteriophage Therapy Revenue by Region (2016-2026)
8.3.2 China Bacteriophage Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Bacteriophage Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Bacteriophage Therapy Market Size and Forecast (2016-2026)
8.3.5 India Bacteriophage Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Bacteriophage Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Bacteriophage Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America Bacteriophage Therapy Revenue by Type (2016-2026)
9.2 South America Bacteriophage Therapy Revenue by Application (2016-2026)
9.3 South America Bacteriophage Therapy Market Size by Country
9.3.1 South America Bacteriophage Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Bacteriophage Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Bacteriophage Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Bacteriophage Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Bacteriophage Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Bacteriophage Therapy Market Size by Country
10.3.1 Middle East & Africa Bacteriophage Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Bacteriophage Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Bacteriophage Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Bacteriophage Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Bacteriophage Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Bacteriophage Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Bacteriophage Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Bacteriophage Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Bacteriophage Therapy Revenue Market Share by Region (2021-2026)
Table 6. Armata Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Armata Pharmaceuticals, Inc. Major Business
Table 8. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product and Solutions
Table 9. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Eliava Biopreparations Ltd. Corporate Information, Head Office, and Major Competitors
Table 11. Eliava Biopreparations Ltd. Major Business
Table 12. Eliava Biopreparations Ltd. Bacteriophage Therapy Product and Solutions
Table 13. Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pherecydes Pharma Corporate Information, Head Office, and Major Competitors
Table 15. Pherecydes Pharma Major Business
Table 16. Pherecydes Pharma Bacteriophage Therapy Product and Solutions
Table 17. Pherecydes Pharma Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Intralytix, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Intralytix, Inc. Major Business
Table 20. Intralytix, Inc. Bacteriophage Therapy Product and Solutions
Table 21. Intralytix, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Phagelux Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Phagelux Inc. Major Business
Table 24. Phagelux Inc. Bacteriophage Therapy Product and Solutions
Table 25. Phagelux Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Nextbiotics Corporate Information, Head Office, and Major Competitors
Table 27. Nextbiotics Major Business
Table 28. Nextbiotics Bacteriophage Therapy Product and Solutions
Table 29. Nextbiotics Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. InnoPhage, Ltd Corporate Information, Head Office, and Major Competitors
Table 31. InnoPhage, Ltd Major Business
Table 32. InnoPhage, Ltd Bacteriophage Therapy Product and Solutions
Table 33. InnoPhage, Ltd Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Locus Biosciences, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Locus Biosciences, Inc. Major Business
Table 36. Locus Biosciences, Inc. Bacteriophage Therapy Product and Solutions
Table 37. Locus Biosciences, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. TechnoPhage Corporate Information, Head Office, and Major Competitors
Table 39. TechnoPhage Major Business
Table 40. TechnoPhage Bacteriophage Therapy Product and Solutions
Table 41. TechnoPhage Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Eligo Bioscience SA Corporate Information, Head Office, and Major Competitors
Table 43. Eligo Bioscience SA Major Business
Table 44. Eligo Bioscience SA Bacteriophage Therapy Product and Solutions
Table 45. Eligo Bioscience SA Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Phagomed Biopharma GmbH. Corporate Information, Head Office, and Major Competitors
Table 47. Phagomed Biopharma GmbH. Major Business
Table 48. Phagomed Biopharma GmbH. Bacteriophage Therapy Product and Solutions
Table 49. Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. PhagePro, Inc. Corporate Information, Head Office, and Major Competitors
Table 51. PhagePro, Inc. Major Business
Table 52. PhagePro, Inc. Bacteriophage Therapy Product and Solutions
Table 53. PhagePro, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Adaptive Phage Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Adaptive Phage Therapeutics, Inc. Major Business
Table 56. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product and Solutions
Table 57. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. EnBiotix, Inc. Corporate Information, Head Office, and Major Competitors
Table 59. EnBiotix, Inc. Major Business
Table 60. EnBiotix, Inc. Bacteriophage Therapy Product and Solutions
Table 61. EnBiotix, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Intodeworld, Inc. Corporate Information, Head Office, and Major Competitors
Table 63. Intodeworld, Inc. Major Business
Table 64. Intodeworld, Inc. Bacteriophage Therapy Product and Solutions
Table 65. Intodeworld, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. BiomX Ltd. Corporate Information, Head Office, and Major Competitors
Table 67. BiomX Ltd. Major Business
Table 68. BiomX Ltd. Bacteriophage Therapy Product and Solutions
Table 69. BiomX Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Phi Therapeutics Corporate Information, Head Office, and Major Competitors
Table 71. Phi Therapeutics Major Business
Table 72. Phi Therapeutics Bacteriophage Therapy Product and Solutions
Table 73. Phi Therapeutics Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Fixed-phage Ltd. Corporate Information, Head Office, and Major Competitors
Table 75. Fixed-phage Ltd. Major Business
Table 76. Fixed-phage Ltd. Bacteriophage Therapy Product and Solutions
Table 77. Fixed-phage Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Micreos BV Corporate Information, Head Office, and Major Competitors
Table 79. Micreos BV Major Business
Table 80. Micreos BV Bacteriophage Therapy Product and Solutions
Table 81. Micreos BV Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. ContraFect Corporation Corporate Information, Head Office, and Major Competitors
Table 83. ContraFect Corporation Major Business
Table 84. ContraFect Corporation Bacteriophage Therapy Product and Solutions
Table 85. ContraFect Corporation Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Global Bacteriophage Therapy Revenue (USD Million) by Players (2019-2021)
Table 87. Global Bacteriophage Therapy Revenue Share by Players (2019-2021)
Table 88. Breakdown of Bacteriophage Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Bacteriophage Therapy Players Head Office, Products and Services Provided
Table 90. Bacteriophage Therapy Mergers & Acquisitions in the Past Five Years
Table 91. Bacteriophage Therapy New Entrants and Expansion Plans
Table 92. Global Bacteriophage Therapy Revenue (USD Million) by Type (2016-2021)
Table 93. Global Bacteriophage Therapy Revenue Share by Type (2016-2021)
Table 94. Global Bacteriophage Therapy Revenue Forecast by Type (2021-2026)
Table 95. Global Bacteriophage Therapy Revenue by Application (2016-2021)
Table 96. Global Bacteriophage Therapy Revenue Forecast by Application (2021-2026)
Table 97. North America Bacteriophage Therapy Revenue by Type (2016-2021) & (USD Million)
Table 98. North America Bacteriophage Therapy Revenue by Type (2021-2026) & (USD Million)
Table 99. North America Bacteriophage Therapy Revenue by Application (2016-2021) & (USD Million)
Table 100. North America Bacteriophage Therapy Revenue by Application (2021-2026) & (USD Million)
Table 101. North America Bacteriophage Therapy Revenue by Country (2016-2021) & (USD Million)
Table 102. North America Bacteriophage Therapy Revenue by Country (2021-2026) & (USD Million)
Table 103. Europe Bacteriophage Therapy Revenue by Type (2016-2021) & (USD Million)
Table 104. Europe Bacteriophage Therapy Revenue by Type (2021-2026) & (USD Million)
Table 105. Europe Bacteriophage Therapy Revenue by Application (2016-2021) & (USD Million)
Table 106. Europe Bacteriophage Therapy Revenue by Application (2021-2026) & (USD Million)
Table 107. Europe Bacteriophage Therapy Revenue by Country (2016-2021) & (USD Million)
Table 108. Europe Bacteriophage Therapy Revenue by Country (2021-2026) & (USD Million)
Table 109. Asia-Pacific Bacteriophage Therapy Revenue by Type (2016-2021) & (USD Million)
Table 110. Asia-Pacific Bacteriophage Therapy Revenue by Type (2021-2026) & (USD Million)
Table 111. Asia-Pacific Bacteriophage Therapy Revenue by Application (2016-2021) & (USD Million)
Table 112. Asia-Pacific Bacteriophage Therapy Revenue by Application (2021-2026) & (USD Million)
Table 113. Asia-Pacific Bacteriophage Therapy Revenue by Region (2016-2021) & (USD Million)
Table 114. Asia-Pacific Bacteriophage Therapy Revenue by Region (2021-2026) & (USD Million)
Table 115. South America Bacteriophage Therapy Revenue by Type (2016-2021) & (USD Million)
Table 116. South America Bacteriophage Therapy Revenue by Type (2021-2026) & (USD Million)
Table 117. South America Bacteriophage Therapy Revenue by Application (2016-2021) & (USD Million)
Table 118. South America Bacteriophage Therapy Revenue by Application (2021-2026) & (USD Million)
Table 119. South America Bacteriophage Therapy Revenue by Country (2016-2021) & (USD Million)
Table 120. South America Bacteriophage Therapy Revenue by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Bacteriophage Therapy Revenue by Type (2016-2021) & (USD Million)
Table 122. Middle East & Africa Bacteriophage Therapy Revenue by Type (2021-2026) & (USD Million)
Table 123. Middle East & Africa Bacteriophage Therapy Revenue by Application (2016-2021) & (USD Million)
Table 124. Middle East & Africa Bacteriophage Therapy Revenue by Application (2021-2026) & (USD Million)
Table 125. Middle East & Africa Bacteriophage Therapy Revenue by Country (2016-2021) & (USD Million)
Table 126. Middle East & Africa Bacteriophage Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Bacteriophage Therapy Picture
Figure 2. Global Bacteriophage Therapy Revenue Market Share by Type in 2020
Figure 3. Oral
Figure 4. Topical
Figure 5. Parenteral
Figure 6. Bacteriophage Therapy Revenue Market Share by Application in 2020
Figure 7. Organ Transplantation Picture
Figure 8. Bacterial Infections Picture
Figure 9. Alcoholic Hepatitis Picture
Figure 10. Other Picture
Figure 11. Global Bacteriophage Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Bacteriophage Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Bacteriophage Therapy Revenue Market Share by Region (2016-2026)
Figure 14. Global Bacteriophage Therapy Revenue Market Share by Region in 2020
Figure 15. North America Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Bacteriophage Therapy Market Drivers
Figure 21. Bacteriophage Therapy Market Restraints
Figure 22. Bacteriophage Therapy Market Trends
Figure 23. Armata Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 24. Eliava Biopreparations Ltd. Recent Developments and Future Plans
Figure 25. Pherecydes Pharma Recent Developments and Future Plans
Figure 26. Intralytix, Inc. Recent Developments and Future Plans
Figure 27. Phagelux Inc. Recent Developments and Future Plans
Figure 28. Nextbiotics Recent Developments and Future Plans
Figure 29. InnoPhage, Ltd Recent Developments and Future Plans
Figure 30. Locus Biosciences, Inc. Recent Developments and Future Plans
Figure 31. TechnoPhage Recent Developments and Future Plans
Figure 32. Eligo Bioscience SA Recent Developments and Future Plans
Figure 33. Phagomed Biopharma GmbH. Recent Developments and Future Plans
Figure 34. PhagePro, Inc. Recent Developments and Future Plans
Figure 35. Adaptive Phage Therapeutics, Inc. Recent Developments and Future Plans
Figure 36. EnBiotix, Inc. Recent Developments and Future Plans
Figure 37. Intodeworld, Inc. Recent Developments and Future Plans
Figure 38. BiomX Ltd. Recent Developments and Future Plans
Figure 39. Phi Therapeutics Recent Developments and Future Plans
Figure 40. Fixed-phage Ltd. Recent Developments and Future Plans
Figure 41. Micreos BV Recent Developments and Future Plans
Figure 42. ContraFect Corporation Recent Developments and Future Plans
Figure 43. Global Bacteriophage Therapy Revenue Share by Players in 2020
Figure 44. Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 45. Global Top 3 Players Bacteriophage Therapy Revenue Market Share in 2020
Figure 46. Global Top 10 Players Bacteriophage Therapy Revenue Market Share in 2020
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 48. Global Bacteriophage Therapy Revenue Share by Type in 2020
Figure 49. Global Bacteriophage Therapy Market Share Forecast by Type (2021-2026)
Figure 50. Global Bacteriophage Therapy Revenue Share by Application in 2020
Figure 51. Global Bacteriophage Therapy Market Share Forecast by Application (2021-2026)
Figure 52. North America Bacteriophage Therapy Sales Market Share by Type (2016-2026)
Figure 53. North America Bacteriophage Therapy Sales Market Share by Application (2016-2026)
Figure 54. North America Bacteriophage Therapy Revenue Market Share by Country (2016-2026)
Figure 55. United States Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Canada Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Mexico Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Europe Bacteriophage Therapy Sales Market Share by Type (2016-2026)
Figure 59. Europe Bacteriophage Therapy Sales Market Share by Application (2016-2026)
Figure 60. Europe Bacteriophage Therapy Revenue Market Share by Country (2016-2026)
Figure 61. Germany Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. France Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. United Kingdom Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Russia Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Italy Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Asia-Pacific Bacteriophage Therapy Sales Market Share by Type (2016-2026)
Figure 67. Asia-Pacific Bacteriophage Therapy Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Bacteriophage Therapy Revenue Market Share by Region (2016-2026)
Figure 69. China Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Japan Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South Korea Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. India Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Southeast Asia Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Australia Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South America Bacteriophage Therapy Sales Market Share by Type (2016-2026)
Figure 76. South America Bacteriophage Therapy Sales Market Share by Application (2016-2026)
Figure 77. South America Bacteriophage Therapy Revenue Market Share by Country (2016-2026)
Figure 78. Brazil Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Argentina Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Middle East and Africa Bacteriophage Therapy Sales Market Share by Type (2016-2026)
Figure 81. Middle East and Africa Bacteriophage Therapy Sales Market Share by Application (2016-2026)
Figure 82. Middle East and Africa Bacteriophage Therapy Revenue Market Share by Country (2016-2026)
Figure 83. Turkey Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Saudi Arabia Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. UAE Bacteriophage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now